Xcout IntelHOLISTA COLLTECH LIMITED competitors & alternatives
The 12 closest competitors and alternatives to HOLISTA COLLTECH LIMITED among household & personal products companies — ranked by similarity to what HOLISTA COLLTECH LIMITED actually does, not by market-cap band.
Subscribe to see HOLISTA COLLTECH LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About HOLISTA COLLTECH LIMITED
Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.
HOLISTA COLLTECH LIMITED at a glance
HOLISTA COLLTECH LIMITED is a household & personal products company headquartered in Subiaco, Australia. It is publicly listed (HCT) with a market capitalisation of $12.6M. Xcout tracks 7 named people at HOLISTA COLLTECH LIMITED, including Charles A Braun (Director).
HOLISTA COLLTECH LIMITED leadership
- Charles A BraunDirector
- Leslie D MichelsonDirector
- Nicholas S SchorschDirector
- Paul N HansonDirector
- Robert BurnsDirector
- Sue Perrotty PortiaDirector
1 more named person on record for HOLISTA COLLTECH LIMITED, with roles, board committees and tenure — see the full roster →
Top 12 HOLISTA COLLTECH LIMITED competitors
Ranked by semantic similarity — how close each company is to HOLISTA COLLTECH LIMITED by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar household & personal products company
Headquartered in West Perth, Australia, Skin Elements Limited is a natural skincare enterprise established in 2015. The company specializes in the development, manufacturing, distribution, and retail of natural, organic, health, and wellness products throughout Australia. Its product offerings include SuprCuvr, a disinfectant spray; Soléo Organics sunscreen; Papaya Activs, formulated for skin condition treatment; and Elizabeth Jane, designed for sensitive skin.
Similar household & personal products company
Headquartered in Sydney, Australia, Bioxyne Limited is a life sciences and health company established in 1998. The firm dedicates itself to the research, development, marketing, and distribution of nutritional supplements and beauty products. Its operations are divided into wholesale and direct sales segments, reaching customers online, through partners, and directly across the United States and Asia. Bioxyne's diverse product line includes functional foods and cosmetic solutions, notably Progastrim for digestive and immune wellness, Progastrim plus Vitamin C for cold symptom relief, and proTract, specifically formulated for infant eczema (atopic dermatitis).
Consumer Staples
New Nordic Healthbrands manufactures and distributes a variety of food supplements to customers globally. The company operates an international e-commerce and retail presence with country-specific websites serving multiple regions across North America, Europe, Asia, and Australia.
Similar household & personal products company
Biome Australia Limited, founded in 2018 and headquartered in Cremorne, Australia, specializes in the development, commercialization, and global distribution of live biotherapeutic and complementary health products. The company's product line features live biotherapeutics under the Activated Probiotics brand, organic nutritional supplements branded as Activated Nutrients, and athletic performance and recovery items named Activated X Performance. These offerings are accessible to consumers through both community pharmacies and independent health practitioners.
Similar household & personal products company
BLS Pharmaceuticals Ltd. engages in the research, development, market and distribution of health products. It operates through the following segments: Wholesale, Plant Based, and Direct Sales. The Wholesale segment covers operation in United States of America (USA), and Asia. The Plant Based segment includes manufacturing, commercialization, and distribution of plant-based products. The Direct Sales segment focuses on Australia, and Asia operation. The company was founded in 1998 and is headquartered in Sydney, Australia.
Similar household & personal products company
The Hydration Pharmaceuticals Company Limited, established in 2001, provides a diverse portfolio of healthy hydration remedies, offered as liquids, tablets, and powders. Operating from its headquarters in San Diego, California, the company distributes these Hydralyte-branded items through both conventional retail outlets and digital e-commerce platforms across Australia, the United States, and Canada.
Similar household & personal products company
Elixinol Wellness Limited, an entity established in 2017 and headquartered in Sydney, Australia, operates internationally through its subsidiaries. The company is primarily involved in the manufacturing and global distribution of a wide array of hemp-derived products, encompassing nutraceuticals, cosmetics, and various food items. These products are marketed under its distinct brands, Elixinol and Hemp Foods Australia, reaching consumers across the Americas, Europe, and Australia. Its extensive product range features hemp-derived cannabidiol (CBD) items, food products, dietary supplements, and topical skincare solutions. Notably, the company transitioned to its current name in May 2021, having previously been known as Elixinol Global Limited.
Consumer Services
Collins Foods Limited operates and manages restaurants across Australia, Europe, and Asia, featuring a diverse portfolio of well-known brands such as KFC, Taco Bell, and Sizzler. As of December 31, 2021, the company oversaw 261 franchised KFC establishments in Australia, alongside 17 in Germany and 45 in the Netherlands. Its Australian operations also included 20 Taco Bell locations, specifically 13 in Queensland, 6 in Victoria, and one in Western Australia. Additionally, Collins Foods managed 66 franchised Sizzler restaurants situated throughout Thailand and Japan. The company was established in 1969 and maintains its headquarters in Hamilton, Australia.
Similar household & personal products company
Star Combo Pharma Limited is involved in the production and supply of health foods and dietary supplements across Australia and China. The company's activities are organized into two primary divisions: Star Combo and Austoyou Retail. It manages the full spectrum of natural health supplements and skincare products, encompassing their development, manufacturing, promotion, and sale. Distribution channels include a dedicated e-commerce platform for health-conscious consumers in China, alongside two brick-and-mortar retail stores situated in Sydney. Founded in 2004, Star Combo Pharma Limited's main office is located in Smithfield, Australia.
Industry
Holiferm is a UK-based biotechnology company headquartered in Wallasey, with research and development facilities in Manchester, driving changes in sustainable bioproducts.
Not Applic
BTC Health Limited operates as a Pooled Development Fund, overseen by LHC Capital Partners Pty Ltd. The fund strategically deploys capital across various corporate development stages, from initial seed and startup funding to early, mid, and late-stage venture growth, and into emerging and established growth companies. Its investment focus lies primarily within the healthcare and biotechnology industries, with a specific emphasis on groundbreaking areas such as post-genomics, which encompasses functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. It also targets stem cell biology, particularly stem cell therapies. Other key areas of interest include convergent technologies, like biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics; silicon biology, involving structure-based drug design, virtual screening, computational library design, and in silico ADME/tox; and nanomedicine. The fund exclusively supports businesses located in Australia, investing in both publicly traded and privately held enterprises.
Regenerative Medicine
Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-mediated and inflammatory diseases. At the core of its innovation is a proprietary regenerative medicine platform utilizing specialized mesenchymal lineage cells. Currently, several of Mesoblast's leading product candidates are undergoing Phase III clinical trials: remestemcel-L, designed for severe, steroid-refractory acute graft versus host disease and acute respiratory distress syndrome associated with COVID-19; Rexlemestrocel-L, aimed at advanced chronic heart failure; and MPC-06-ID, intended for chronic low back pain stemming from degenerative disc disease. Additionally, MPC-300-IV is being developed for biologic-refractory rheumatoid arthritis and diabetic nephropathy. The company has cultivated strategic partnerships to advance its pipeline and market reach. These collaborations include Tasly Pharmaceutical Group for the distribution of MPC-150-IM (heart failure) and MPC-25-IC (heart attacks) in China; JCR Pharmaceuticals Co. Ltd. for therapies addressing wound healing in patients with epidermolysis bullosa; and Grünenthal for the development and commercialization of cell therapy solutions for chronic low back pain. Mesoblast Limited was established in 2004 and maintains its headquarters in Melbourne, Australia.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of HOLISTA COLLTECH LIMITED and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for HOLISTA COLLTECH LIMITEDand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →